Skip to main content
Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
321.43
-7.58 (-2.30%)
At close: Apr 28, 2026, 4:00 PM EDT
322.45
+1.02 (0.32%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Stryker Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Medsurg and Neurotechnology
15.65B 14.97B 14.39B 13.73B 13.22B 12.77B 12.40B 12.15B
Medsurg and Neurotechnology Growth
18.34% 17.23% 16.01% 13.08% 11.71% 11.40% 10.84% 11.65%
Orthopedics and Spine
9.47B 9.41B 9.43B 9.48B 9.37B 9.21B 8.99B 8.82B
Orthopedics and Spine Growth
1.02% 2.25% 4.93% 7.55% 8.21% 9.28% 8.72% 9.21%

Medsurg and Neurotechnology Revenue Breakdown
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Medical
4.20B 4.06B 4.02B 3.93B 3.85B 3.75B 3.61B 3.55B
Medical Growth
9.14% 8.26% 11.16% 10.94% 11.36% 11.90% 8.80% 12.72%
Endoscopy
3.81B 3.67B 3.61B 3.48B 3.39B 3.28B 3.18B 3.11B
Endoscopy Growth
12.33% 12.00% 13.63% 11.73% 11.74% 15.48% 18.15% 20.52%
Instruments
3.18B 3.05B 2.97B 2.90B 2.83B 2.78B 2.73B 2.66B
Instruments Growth
12.31% 9.64% 8.72% 8.87% 10.32% 11.83% 14.04% 14.40%
Neuro Cranial
2.49B 2.42B 2.22B 2.02B 1.84B 1.67B 1.62B 1.57B
Neuro Cranial Growth
35.05% 44.50% 37.48% 28.53% 18.79% 11.90% 11.98% 11.79%
Neurovascular
1.97B 1.77B 1.57B 1.40B 1.31B 1.29B 1.27B 1.25B
Neurovascular Growth
50.57% 37.64% 24.13% 12.06% 6.61% 6.72% 6.73% 5.83%

Orthopedics and Spine Revenue Breakdown
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Trauma and Extremities
3.95B 3.86B 3.75B 3.62B 3.51B 3.37B 3.27B 3.21B
Trauma and Extremities Growth
12.57% 14.45% 14.45% 12.91% 11.44% 10.13% 9.83% 10.97%
Knees
2.66B 2.59B 2.54B 2.50B 2.45B 2.39B 2.34B 2.30B
Knees Growth
8.54% 8.54% 8.61% 8.85% 7.66% 8.88% 8.05% 9.34%
Hips
1.87B 1.83B 1.79B 1.75B 1.70B 1.66B 1.60B 1.56B
Hips Growth
9.45% 10.51% 12.21% 12.29% 10.36% 9.97% 7.18% 6.91%
Other
815.00M 770.00M 694.00M 647.00M 618.00M 562.00M 565.00M 548.00M
Other Growth
31.88% 37.01% 22.83% 18.07% 21.41% 13.31% 18.45% 16.10%
Spine
- - - 963.00M 1.10B 1.23B 1.22B 1.21B
Spine Growth
- - - -20.08% -7.74% 5.22% 5.10% 4.69%

Revenue by Geography
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
International
6.11B 5.94B 5.84B 5.75B 5.65B 5.55B 5.39B 5.30B
International Growth
8.10% 7.12% 8.31% 8.39% 7.84% 8.32% 7.66% 8.09%
United States
5.44B 4.57B 4.55B 4.44B 4.87B 4.11B 4.05B 3.91B
United States Growth
11.66% 11.24% 12.53% 13.44% 11.87% 11.72% 9.05% 11.45%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.